ArticleFrontiers in immunology2025

Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.